Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.

Conditions:   Ovary Cancer;   Cervix Cancer;   Endometrium Cancer;   Bladder Cancer;   Prostate Cancer;   Esophagus Cancer;   Lung Cancer, Nonsmall Cell;   Squamous Cell Carcinoma of the Head and Neck
Intervention:   Drug: Tisotumab Vedotin
Sponsor:   Genmab
Recruiting - verified August 2017

http://ift.tt/2vS7sps